1. Dopamine CDA) is a protective agent in the gastrointestinal (Gn tract in
both rats and humans, Therefore, we have studied the site of DA production
in rat and human GI tract using a variety of techniques, including immunoc
ytochemistry (ICC), in situ hybridization histochemistry, reverse transcrip
tion-polymerase chain reaction, HPLC, western blotting and immunoelectron m
icroscopy,
2. We found very high concentrations of DA that persisted after chemical sy
mpathectomy (CS) in the gastric juice, the stomach mucosa and in the pancre
as. Both the stomach mucosa and the pancreas also had tyrosine hydroxylase
(TN) activity, most of which remained after CS, Double-labelling ICC showed
that acid-producing parietal cells and the exocrine pancreas must also be
capable of producing DA,
3. We isolated rat stomach parietal cells by cell fractionation and found t
hat both DA and TN activity are present in isolated (denervated) parietal c
ells, These cells also have other features of aminergic cells: they are imm
uno- (and mRNA) positive for the DA plasma membrane transporter and vesicul
ar monoamine transporter(s), In both gastric and duodenal mucosa, we demons
trated the presence of significant amounts of the D5 receptor that could se
rve as a target for locally produced DA,
4. Because DA, its biosynthetic enzymes and ifs transporters are also found
in parietal cells in the human stomach, a mucosal protective system involv
ing DA could be important clinically.